LEVOFLOXACIN DISK POTENCY AND TENTATIVE INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTS

被引:17
作者
PFALLER, MA
BARRY, AL
FUCHS, PC
机构
[1] CLIN MICROBIOL INST INC,TUALATIN,OR 97062
[2] ST VINCENT HOSP & MED CTR,PORTLAND,OR 97225
关键词
D O I
10.1128/JCM.31.7.1924-1926.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Levofloxacin disk susceptibility test criteria were evaluated by testing 350 bacterial isolates. Either 5- or 10-mug disks could be used satisfactorily. A 5-mug levofloxacin disk with zone size-breakpoints of less-than-or-equal-to 12 mm for resistance (MIC, greater-than-or-equal-to 8.0 mug/ml) and greater-than-or-equal-to 16 mm for susceptibility (MIC, less-than-or-equal-to 2.0 mug/ml) is recommended.
引用
收藏
页码:1924 / 1926
页数:3
相关论文
共 13 条
[1]   TEMAFLOXACIN DISK POTENCY AND TENTATIVE INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTS [J].
BARRY, AL ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2861-2863
[2]   A COMPARISON OF ANTIMICROBIAL ACTIVITY OF OFLOXACIN, L-OFLOXACIN, AND OTHER ORAL-AGENTS FOR RESPIRATORY PATHOGENS [J].
CHERUBIN, CE ;
ENG, RHK ;
SMITH, SM ;
TAN, EN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (02) :141-144
[3]   INVITRO ACTIVITY OF L-OFLOXACIN AGAINST NORFLOXACIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI [J].
FOLENO, B ;
FU, KP .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (06) :557-559
[4]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF LEVOFLOXACIN (L-OFLOXACIN), AN OPTICALLY-ACTIVE OFLOXACIN [J].
FU, KP ;
LAFREDO, SC ;
FOLENO, B ;
ISAACSON, DM ;
BARRETT, JF ;
TOBIA, AJ ;
ROSENTHALE, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :860-866
[5]   OFLOXACIN SUSCEPTIBILITY TESTING QUALITY-CONTROL PARAMETERS FOR MICRODILUTION AND DISK DIFFUSION, AND CONFIRMATION OF DISK DIFFUSION INTERPRETIVE CRITERIA [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
GAVAN, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (01) :49-52
[6]   PROPOSED DISK DIFFUSION SUSCEPTIBILITY CRITERIA FOR OFLOXACIN [J].
FUCHS, PC ;
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :310-311
[7]   PHARMACOKINETICS OF OFLOXACIN AFTER PARENTERAL AND ORAL-ADMINISTRATION [J].
LODE, H ;
HOFFKEN, G ;
OLSCHEWSKI, P ;
SIEVERS, B ;
KIRCH, A ;
BORNER, K ;
KOEPPE, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1338-1342
[8]   SUSCEPTIBILITY TESTS OF ANAEROBIC BACTERIA - STATISTICAL AND CLINICAL CONSIDERATIONS [J].
METZLER, CM ;
DEHAAN, RM .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (06) :588-594
[9]   INVITRO ACTIVITY OF S-OFLOXACIN [J].
NEU, HC ;
CHIN, NX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1105-1107
[10]   ENANTIOSELECTIVE DISPOSITION OF OFLOXACIN IN HUMANS [J].
OKAZAKI, O ;
KOJIMA, C ;
HAKUSUI, H ;
NAKASHIMA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2106-2109